Fujifilm Holdings reported its first-quarter results for the fiscal year ending March 2027, with revenue rising 10.3% year-on-year to 826.5 billion yen, a double-digit increase, but operating profit tumbled 32.0% to 51.2 billion yen. The stock plunged 16.6% from the previous day to 3,236 yen. Factors behind the profit decline include higher fixed costs in the healthcare segment's bio CDMO business, one-time expenses related to strengthening the business innovation segment, and the impact of soaring raw material prices. The full-year revenue forecast was raised to 3.56 trillion yen, reflecting strong semiconductor materials sales and currency effects, but the operating profit forecast was left unchanged at 365 billion yen, with first-quarter progress at only around 15%. The market reacted warily to the contrasting figures of an upward revenue revision and an unchanged profit plan, with the price-to-book ratio falling below 1 times to 0.99 times.
FUJIFILM Holdings CorpOperating profit dropped 32% in Q1, triggering a 16.6% stock plunge.
